The Royal Brompton and Harefield Clinical Group Board is a formal sub-committee of the Guy's and St Thomas' NHS Foundation Trust Board, with delegated responsibilities and decision-making rights for the strategic and operational running of its services. These are set out in the Guy’s and St Thomas’ Scheme of Delegation, and the Trust’s Standing Financial Instructions provide the delegation limits with regard to financial decisions.
The Guy’s and St Thomas’ NHS Foundation Trust Board of Directors holds legal accountability for the Trust including all aspects of the Royal Brompton and Harefield Clinical Group. The Royal Brompton and Harefield Clinical Group Board provides assurance to the Guy’s and St Thomas’ NHS Foundation Trust Board of Directors on the overall operational, quality and safety and financial performance of Royal Brompton and Harefield hospitals, and on the development and delivery of the Trust's strategy for its heart and lung services.
* voting member of the Guy’s and St Thomas’ Board
Lawrence was appointed as deputy chief executive of the Trust in March 2020. Prior to joining Guy’s and St Thomas' he was director of strategy, planning and performance at University Hospitals Birmingham NHS Foundation Trust.
Lawrence has held a wide range of healthcare leadership roles, both in the UK and abroad. He also worked at the Department of Health in the offices of both the Secretary of State and the NHS chief executive and was previously managing director of the Shelford Group, a collaboration of ten NHS trusts working together with national leaders to inform life science, health and social care policy.
Avey joined Guy's and St Thomas' NHS Foundation Trust as chief nurse and vice president of the Florence Nightingale Foundation in November 2020.
She returned to the Trust having trained as a critical care nurse at St Thomas' in the early part of her career. Her clinical experience includes theatres, general intensive care, coronary care and cardiothoracic nursing. Avey holds a postgraduate diploma in health services management and a Masters in public administration.
Avey qualified in 1991, having trained at Maidstone Hospital in Kent. She has held various staff nurse and sister posts at hospitals in London including St George's, where she moved into management, eventually becoming a divisional director of nursing.
In 2011, she was appointed deputy chief nurse at South London Healthcare Trust and became chief nurse at Maidstone and Tunbridge Wells Trust in 2013. She started as chief nurse and director of infection prevention and control at St George's University Hospitals NHS Foundation Trust in February 2017 and from February 2020 had been carrying out the role of chief operating officer, helping to lead St George's response to coronavirus (Covid-19).
Dr Richard Grocott-Mason has been a consultant cardiologist for over 19 years and has led the transformation of clinical services to help deliver large scale care for patients with heart and lung conditions. He was appointed managing director of the Royal Brompton and Harefield Clinical Group in February 2021.
Dr Grocott-Mason graduated from Jesus College, Oxford and St Thomas’ Hospital Medical School, London, qualifying in 1986. He has been a consultant cardiologist since 1999, initially at Harefield Hospital and Hillingdon Hospital, where he was also joint medical director and responsible officer, before joining Royal Brompton and Harefield hospitals full time in 2014.
In December 2015, Dr Grocott-Mason was appointed interim medical director and responsible officer of Royal Brompton and Harefield hospitals. He was appointed to the permanent post in 2016.
In July 2019, Dr Grocott-Mason was appointed managing director of the RBH-KHP Partnership, a role which he held until November 2020.
Dr Grocott-Mason is an interventional cardiologist performing coronary angioplasty as part of the team providing the primary angioplasty service at Harefield Hospital's heart attack centre. His adult cardiology experience includes assessment of coronary artery disease, valve disease and heart failure.
Dr Mark Mason is a consultant cardiologist at Harefield Hospital with expertise in coronary intervention, formerly the hospital's divisional director for heart. He was seconded to the role of medical director at Royal Brompton and Harefield hospitals in July 2019, before being appointed to the permanent post.
Dr Mason is nationally recognised as a specialist in pacing lead extraction and has been a specialist advisor to the National Institute for Health and Care Excellence (NICE) on the use of laser sheaths to remove pacing leads.
Dr Mason has played a key role in developing the nationally acclaimed primary angioplasty programme at Harefield Hospital. He has also developed one of the busiest pacing services in the UK, delivering a complete range of pacing implantation and extraction techniques.
He is actively involved in developing innovative pathways to make smoother transitions between primary care and secondary/tertiary care, to improve the patient journey at both a local and regional level.
He is also a member of the Pan-London Arrhythmia Group looking to improve both elective and emergency care of patients with arrhythmias.
Robert joined Harefield Hospital in 1995, having previously worked in community and general hospital services.
Following the merger of Royal Brompton Hospital and Harefield Hospital in 1998, he became site director at Harefield and, in 2001, deputy director of operations for Royal Brompton and Harefield hospitals.
Robert has also fulfilled the roles of director of governance and quality (2003 to 2006) and director of planning and strategy (2006 to 2009). In the latter post he was responsible for the Trust’s foundation trust application.
He was appointed to the role of chief operating officer in 2008 and director of development and partnerships in 2018.
Richard joined Royal Brompton and Harefield hospitals as chief financial officer in January 2020 from EY (Ernst & Young) where he was a partner and UK health sector leader.
After obtaining a BA and PhD in Physics, he worked initially for the consultancy Arthur D Little, and then the investment bank, Rothschild before joining Monitor, the Independent Regulator of NHS Foundation Trusts in 2009, where he was responsible for assessing Trusts for FT status, regulating financially challenged FTs and reviewing Trust mergers. He then joined EY in 2012 where he advised NHS Trusts on financial improvement, integration and collaboration, and capital schemes.
Richard is a trustee of Pathway, a charity focused on supporting homeless people in hospitals.
Nicholas is director of service development and also site director at Harefield Hospital, a role he took on in 2006. He has worked at Royal Brompton and Harefield hospitals following their merger in 1998.
Mr Hunt began his career at Regional HQ, the forerunner of strategic health authorities. His subsequent career in NHS management has included both operational and strategic roles at a number of London hospitals.
Baroness Sally Morgan was made a life peer in 2001. She has served as minister of state in the Cabinet Office, political secretary to the prime minister and director of government relations at 10 Downing Street, chair of OFSTED and board member of the Olympic Delivery Authority.
Baroness Morgan was appointed chair of Royal Brompton & Harefield NHS Foundation Trust in 2017. Following the Trust's merger with Guy's and St Thomas' NHS Foundation in February 2021, she was appointed chair of the Royal Brompton and Harefield Clinical Group.
After serving as a local councillor and working as a secondary school teacher, Baroness Morgan worked for Tony Blair when he was leader of the opposition. Following the 1997 general election, she was appointed as political secretary to the Prime Minister and head of the Prime Minister's political office. She then served as minister of state in the Cabinet Office before returning to Downing Street as director of government relations.
Since leaving government in 2005, Baroness Morgan has held a number of appointments in the public and private sector. She was the chair of OFSTED, the Office for Standards in Education, from 2011 – 2014 and sat on the board of the Olympic Delivery Authority for its six-year duration. She is currently a member of the House of Lords Science & Technology Select Committee.
Baroness Morgan has been a lay member of the Council of King’s College London, since 2013, and was appointed vice-chair in September 2016. She is also a visiting professor for the Policy Institute there. In 2019, Baroness Morgan was appointed Master of Fitzwilliam College at the University of Cambridge.
She is chair of Ambition School Leadership (a UK education charity) and board adviser to Ark, which runs academies in the UK and works internationally in education. She is a non-executive director of Countryside Properties PLC.
Simon joined Royal Brompton and Harefield hospitals as a non-executive member in August 2017. He was a chartered accountant and partner at PricewaterhouseCoopers LLP (PwC), where his career spanned more than 30 years. He has extensive experience of finance and audit in healthcare, pharmaceutical and life sciences settings, leading the firm’s Global Pharmaceutical and Life Sciences Industry Group, and was a member of PwC’s UK and Global Board.
He has a depth of expertise in finance and audit, as well as a thorough understanding of governance across a range of sectors, technical rigour and board experience at the highest level. Simon is also a trustee and Chair, Community Services at Jewish Care, a charity providing residential and day care facilities and is a member of the General Council at the Royal Academy of Arts and on the Board of Bevan Brittan LLP, a Bristol-based law firm.
Dr Felicity Harvey joined the Guy's and St Thomas' Board in September 2016. She was director general for Public and International Health, until her retirement from the civil service in June 2016. Prior to that, she was director of the Prime Minister’s Delivery Unit.
After qualifying in medicine in 1980 at St Bartholomew’s Medical College, London, she completed an International MBA.
Her previous roles include private secretary to the Chief Medical Officer and Head of Medicines, Pharmacy and Industry Group at the Department of Health.